248 related articles for article (PubMed ID: 8135480)
1. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in the normal female breast.
Ricketts D; Turnbull L; Ryall G; Bakhshi R; Rawson NS; Gazet JC; Nolan C; Coombes RC
Cancer Res; 1991 Apr; 51(7):1817-22. PubMed ID: 2004366
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
5. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
Balleine RL; Earl MJ; Greenberg ML; Clarke CL
Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
[TBL] [Abstract][Full Text] [Related]
6. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
7. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
9. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
11. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
12. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
[TBL] [Abstract][Full Text] [Related]
13. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis.
Vielh P; Magdelénat H; Mosseri V; Remvikos Y; di Bonito L
Am J Clin Pathol; 1992 Feb; 97(2):254-61. PubMed ID: 1546694
[TBL] [Abstract][Full Text] [Related]
15. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
[TBL] [Abstract][Full Text] [Related]
16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
19. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative immunocytochemical estrogen receptor determination in fine needle aspirates in breast cancer using monoclonal antibodies].
Kübler HC; Kühn W; Rummel HH; Krapfl E; Klinga K
Geburtshilfe Frauenheilkd; 1988 Nov; 48(11):763-7. PubMed ID: 3234709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]